Assessment of the Performance of the Aptima Bacterial Vaginosis Assay Over a 3-Month Period in a French Hospital
- PMID: 35980223
- PMCID: PMC9602445
- DOI: 10.1128/spectrum.01301-22
Assessment of the Performance of the Aptima Bacterial Vaginosis Assay Over a 3-Month Period in a French Hospital
Abstract
Bacterial vaginosis (BV) is the most common cause of abnormal vaginal discharge. BV represents a dysbiosis with the acquisition of a diverse community of anaerobic bacteria and a reduction in lactobacilli burden. Our objective was to evaluate the Aptima BV assay kit for the diagnosis of BV. From May to August 2019, we enrolled outpatients and inpatients, including nonpregnant women above 18 with vaginosis symptoms, consulting at Nantes University hospital. The Aptima BV assay measures the loads of Gardnerella vaginalis, Atopobium vaginae, and Lactobacillus species in relation to overall bacterial load. The Aptima BV assay was compared to Nugent scoring (NS). A total of 456 women were enrolled, and 347 patients met the inclusion criteria with data available for the analysis. NS was used to classify the samples and 144 (41.5%) samples were classified as normal (NS = 0-3), 45 (13%) as BV (NS = 7-10), 38 (11%) presented an intermediate vaginal microbiota (3 < NS < 7), 79 (22.7%) had various bacteria (excluding vaginal flora), 29 (8.3%) had insufficient bacterial density, and 12 (3.5%) had a predominance of yeasts. The Aptima BV kit displayed a sensitivity of 91.1% and specificity of 94.4% with a positive predictive value (PPV) of 83.7% and a negative predictive (NPV) value of 97.1%. The results of this monocentric retrospective study show that Aptima BV kit has a good diagnostic correlation compared to standard of care for dysbiotic diagnosis cases. IMPORTANCE The possibility exists of the involvement of a new molecular test in the routine algorithm of bacterial vaginosis diagnosis in microbiology laboratories. This manuscript reports on our experience, and we propose an organization combining Nugent scoring and molecular testing, especially for intermediate Nugent scores.
Keywords: Atopobium vaginae; Gardnerella vaginalis; Lactobacillus; Nugent scoring; bacterial vaginosis; molecular test.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients.Hum Reprod. 2016 Apr;31(4):795-803. doi: 10.1093/humrep/dew026. Epub 2016 Feb 23. Hum Reprod. 2016. PMID: 26911864
-
Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S106-12. doi: 10.1097/MCG.0000000000000226. J Clin Gastroenterol. 2014. PMID: 25291116 Clinical Trial.
-
Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis.Clin Infect Dis. 2008 Jul 1;47(1):33-43. doi: 10.1086/588661. Clin Infect Dis. 2008. PMID: 18513147
-
Characterization of the vaginal microflora in health and disease.Dan Med J. 2014 Apr;61(4):B4830. Dan Med J. 2014. PMID: 24814599 Review.
-
Bacterial Vaginosis: What Do We Currently Know?Front Cell Infect Microbiol. 2022 Jan 18;11:672429. doi: 10.3389/fcimb.2021.672429. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35118003 Free PMC article. Review.
Cited by
-
Clinical laboratory evaluation of the Hologic Panther Aptima BV and CV/TV assays for the diagnosis of vaginitis in Dunedin, Aotearoa New Zealand.Microbiol Spectr. 2025 Jan 7;13(1):e0127424. doi: 10.1128/spectrum.01274-24. Epub 2024 Nov 19. Microbiol Spectr. 2025. PMID: 39560428 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous